Comparative analysis of EZH2, p16 and p53 expression in uterine carcinosarcomas
Introduction: The role of p16 and p53 immunohistochemistry in the diagnosis of rare and aggressive uterine carcinosarcoma (UCS) has been well established. However, enhancer of zeste homolog 2 (EZH2), a histone methyltransferase and a member of the polycomb group family is a relatively new biomarker,...
Saved in:
Main Authors: | Evelin Makk (Author), Noémi Bohonyi (Author), Angéla Oszter (Author), Klára Éles (Author), Tamás Tornóczky (Author), Arnold Tóth (Author), Endre Kálmán (Author), Krisztina Kovács (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sodium Valproate Inhibits Small Cell Lung Cancer Tumor Growth on the Chicken Embryo Chorioallantoic Membrane and Reduces the p53 and EZH2 Expression
by: Lina Šlekienė, et al.
Published: (2018) -
Uterine Carcinosarcoma in a Patient with Didelphys Uterus
by: C. Iavazzo, et al.
Published: (2013) -
Fatal pulmonary thromboembolism associated with uterine carcinosarcoma
by: Giorgia Lodetti, et al.
Published: (2023) -
Diagnostic value of progesterone receptor and p53 expression in uterine smooth muscle tumors
by: Hewedi Iman H, et al.
Published: (2012) -
Clostridium and Bacteroides bacteremia as initial presentation of uterine carcinosarcoma
by: Chinonye S. Imo, et al.
Published: (2022)